| Migraine Quantity Limit |
Amerge (naratriptan), Frova (frovatriptan), Imitrex (sumatriptan) tablets and nasal spray, Onzetra (sumatriptan), Relpax (eletriptan), Tosymra (sumatriptan), Zembrace SymTouch (sumatriptan), Zomig (zolmitriptan) tablets, Zomig-ZMT (zolmitriptan), Axert (almotriptan), D.H.E. 45 (dihydroergotamine mesylate) injection, Imitrex (sumatriptan) injection, Maxalt (rizatriptan), Maxalt-MLT (rizatriptan), Migranal (dihydroergotamine mesylate), Nurtec ODT (rimegepant sulfate), Treximet (sumatriptan/naproxen), Trudhesa (dihydroergotamine mesylate), Ubrelvy (ubrogepant), Zavzpret (zavegepant), Zomig (zolmitriptan) nasal spray |
| Miplyffa (arimoclomol) |
Miplyffa (arimoclomol) |
| Mitoxantrone |
Mitoxantrone |
| Molluscum Contagiosum Agents |
Ycanth (cantharidin solution), Zelsuvmi (berdazimer) topical gel |
| Monoclonal Antibody Agents for Alzheimer's Disease - PA, NF |
Aduhelm (aducanumab-avwa), Kisunla (donanemab-azbt), Leqembi (lecanemab-irmb) |
| Mulpleta (lusutrombopag) |
Mulpleta (lusutrombopag) |
| Multiple Sclerosis (MS) Agents - PA, NF |
Aubagio (teriflunomide), Avonex (interferon beta-1a), Bafiertam (monomethyl fumarate), Betaseron (interferon beta-1b), Briumvi (ublituximab-xiiy), Copaxone (glatiramer acetate), Extavia (interferon beta-1b), Glatopa (glatiramer acetate), Kesimpta (ofatumumab), Mayzent (siponimod), Plegridy (peginterferon beta-1a), Ponvory (ponesimod), Rebif (interferon beta-1a), Vumerity (diroximel fumarate), Lemtrada (alemtuzumab), Mavenclad (cladribine), Ocrevus (ocrelizumab), Ocrevus Zunovo (ocrelizumab), Tascenso ODT (fingolimod) |
| Myalept (metreleptin for injection) |
Myalept (metreleptin for injection) |
| Myobloc (rimabotulinumtoxin B) |
Myobloc (rimabotulinumtoxin B) |
| Naglazyme (galsulfase injection) |
Naglazyme (galsulfase injection) |
| Nasal Steroids |
Xhance (fluticasone propionate) |
| Nascobal (cyanocobalamin) Spray- Non Formulary |
Nascobal (cyanocobalamin) Spray |
| Nemluvio (nemolizumab-ilto) |
Nemluvio (nemolizumab-ilto) |
| Nerlynx (neratinib) |
Nerlynx (neratinib) |
| Neurologic Agents |
Gralise (gabapentin), Lyrica CR (pregabalin extended-release), Savella (milnacipran) |
| New Drug to Market Program - PA |
New drug to market |
| Nexavar (sorafenib) |
Nexavar (sorafenib) |
| Nexletol (bempedoic acid) and Nexlizet (bempedoic acid-ezetimibe) |
Nexletol (bempedoic acid), Nexlizet (bempedoic acid-ezetimibe) |
| Nexviazyme (avalglucosidase alfa-ngpt) |
Nexviazyme (avalglucosidase alfa-ngpt) |
| Niktimvo (axatilimab-csfr)- PA, NF |
Niktimvo (axatilimab-csfr) |
HEALTHY LIVING